Occupational Exposure Assessment and Safety Management of Antineoplastic Drugs in Four PIVAS in#br#
Dali Bai Autonomous Prefecture
Xiao Shanrui1, Gu Yun1, Xie Yuxuan2, Wang Haixiu3, Zhang Gang4, Wei Zhengxiang5, Li Xia1*
(1. Pharmacy Intravenous Admixture Service, The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, China; 2. College
of Pharmacy, Dali University, Dali, Yunnan 671000, China; 3. Dali Bai Autonomous Prefecture People′s Hospital, Dali, Yunnan
671000, China; 4. The First People′s Hospital of Dali City, Dali, Yunnan 671000, China; 5. The People′s Hospital of Xiangyun,
Xiangyun, Yunnan 672100, China)
Xiao Shanrui, Gu Yun, Xie Yuxuan, Wang Haixiu, Zhang Gang, Wei Zhengxiang, Li Xia. Occupational Exposure Assessment and Safety Management of Antineoplastic Drugs in Four PIVAS in#br#
Dali Bai Autonomous Prefecture[J]. Journal of Dali University, 2026, 11(2): 22-30.
〔1〕 HUANG X H, GAO C X, CAI W Z, et al. Effect of Occu⁃
pational Exposure to Antineoplastic Drugs on DNA Damage
in Nurses: A Cross-Sectional Study〔J〕. Occup Environ
Med, 2022, 79(4): 253-258.
〔2〕 BRAY F, LAVERSANNE M, SUNG H, et al. Global Can⁃
cer Statistics 2022: GLOBOCAN Estimates of Incidence
and Mortality Worldwide for 36 Cancers in 185 Coun⁃
tries〔J〕. CA Cancer J Clin, 2024, 74(3): 229-263.
〔3〕 郝梦琳. 抗肿瘤药物注射剂暴露风险与分级管控研
究〔D〕. 成都:电子科技大学, 2020.
〔4〕 肖杉蕊,李霞,邱琳,等.滇西地区静脉用药调配中心工
作人员抗肿瘤药物职业暴露及防护的调查研究〔J〕.大
理大学学报, 2025, 10(4): 21-26.
〔5〕 PINET E, CIRTIU C M, CARON N, et al. Canadian Moni⁃
toring Program of the Surface Contamination with 11 Anti⁃
neoplastic Drugs in 124 Centers〔J〕. J Oncol Pharm Pract,
2024, 30(1): 19-29.
〔6〕 YUAN Z, LI Q, TANG T, et al. Studies on the Optimiza⁃
tion of Decontamination Protocol for Surfaces Contaminated
with Cytotoxic Drugs in PIVAS〔J〕. J Oncol Pharm Pract,
2023, 29(7): 1565-1573.
〔7〕 SANTOS A N, OLIVEIRA R J, PESSATTO L R, et al.
Biomonitoring of Pharmacists and Nurses at Occupational
Risk from Handling Antineoplastic Agents〔J〕. Int J Pharm
Pract, 2020, 28(5): 506-511.
〔8〕 CHAUCHAT L, TANGUAY C, CAARON N J, et al. Sur⁃
face Contamination with Ten Antineoplastic Drugs in 83
Canadian Centers〔J〕. J Oncol Pharm Pract, 2019, 25(5):
1089-1098.
〔9〕 耿洲,王洋,屈昱晨,等. 15种细胞毒性抗肿瘤药物在我
院PIVAS中的环境残留检测及清洁方法〔J〕. 中国药房,
2023, 34(2): 217-222.
〔10〕 DUGHERI S, BONARI A, POMPILIO I, et al. A New
Approach to Assessing Occupational Exposure to Antineo⁃
plastic Drugs in Hospital Environments〔J〕. Arh Hig Rada
Toksikol, 2018, 69(3): 226-237.
〔11〕 侯洁,郝志英,段金菊. 不同医院不同环境表面化疗药
物污染情况调查〔J〕. 药物流行病学杂志, 2018, 27
(1): 49-52.
〔12〕 梅小红,张艳芳,林怡然,等. 医护人员职业接触抗肿瘤
药物的环境暴露评估〔J〕. 中国预防医学杂志, 2022,
23(11): 845-850.
〔13〕 CARVALHO L, SILVA D, RIBEIRO L, et al. Nephelometry
vs. Immunoturbidimetry Assay: Analytical Perfor⁃
mance on IgG Subclasses〔J〕. J Immunol Methods, 2024,
532: 113725.
〔14〕 CONNOR T H, ZOCK M D, SNOW A H. Surface Wipe
Sampling for Antineoplastic (Chemotherapy) and Other
Hazardous Drug Residue in Healthcare Settings: Methodology
and Recommendations〔J〕. J Occup Environ Hyg,
2016, 13(9): 658-667.
〔15〕 URSINI C L, DI BASILIO M, CIERVO A, et al. Bio⁃
monitoring of Workers Employed in a Titanium Dioxide
Production Plant: Use of Buccal Micronucleus Cytome As⁃
say as Noninvasive Biomarker to Evaluate Genotoxic and
Cytotoxic Effects〔J〕. Environ Mol Mutagen, 2021, 62
(4): 242-251.
〔16〕 VILLA A, TREMOLET K, MARTINEZ B, et al. A Highly
Sensitive UHPLC-MS/MS Method for Urine Biological
Monitoring of Occupational Exposure to Anthracycline
Antineoplastic Drugs and Routine Application〔J〕. J Chromatogr
B Analyt Technol Biomed Life Sci, 2020, 1156: 122305.
〔17〕 SANTONEN T, PORRAS S P, BOCCA B, et al.
HBM4EU Chromates Study - Overall Results and Recom⁃
mendations for the Biomonitoring of Occupational Expo⁃
sure to Hexavalent Chromium〔J〕. Environ Res, 2022,
204(Pt A): 111984.
〔18〕 姚孟颖,尹晓华. 基于M-SHEL 模型构建静脉用药调配